Clinuvel Pharmaceuticals, Ltd. (OTC Pink: CLVLY) (ASX: CUV) Jumps 40% after FDA Approves SCENESSE for Rare Genetic Metabolic Disorder, Erythropoietic Protoporphyria (EPP)
Clinuvel Pharmaceuticals, Ltd. (OTC Pink: CLVLY) (ASX: CUV) is a global biopharmaceutical company based out of Melbourne, Australia. The biopharma ...
